• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初步证据表明,一种色氨酸合成酶E(trpE)-戊型肝炎病毒(HEV)融合蛋白可保护食蟹猴免受野生型戊型肝炎病毒(HEV)攻击。

Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV).

作者信息

Purdy M A, McCaustland K A, Krawczynski K, Spelbring J, Reyes G R, Bradley D W

机构信息

Hepatitis Branch, Centers for Disease Control, Atlanta, Georgia 30333.

出版信息

J Med Virol. 1993 Sep;41(1):90-4. doi: 10.1002/jmv.1890410118.

DOI:10.1002/jmv.1890410118
PMID:8228944
Abstract

Immunization of two cynomolgus macaques (cynos) with trpE-C2 protein, a trpE-HEV fusion protein that represents the carboxyl two thirds of the putative capsid protein, prevented development of biochemical evidence of viral hepatitis in these primates after challenge by wild-type HEV from either a Burmese or Mexican stool isolate. Neither of the immunized animals showed any elevation of alanine aminotransferase activity after challenge with wild-type HEV in marked contrast with the unimmunized (control) cynos. In the case of the Burmese HEV challenged cyno, the protective effect was complete with the animal failing to demonstrate any evidence of HEV infection. The immunized cyno challenged with Burmese HEV did not exhibit any HEV RNA in its stools or HEV antigen in its liver. The immunized cyno (#8902) challenged with Mexican virus exhibited HEV RNA in its stools and HEV antigen in its liver; however, microscopic examination of liver biopsy specimens from this cyno failed to detect histopathologic evidence of viral hepatitis. All of the animals (naive and immunized) developed anti-HEV IgM and IgG responses after HEV challenge. Our preliminary studies indicate that the trpE-C2 protein is a promising candidate HEV vaccine.

摘要

用trpE-C2蛋白(一种代表假定衣壳蛋白羧基三分之二的trpE-戊型肝炎病毒融合蛋白)对两只食蟹猴进行免疫,可防止这些灵长类动物在受到来自缅甸或墨西哥粪便分离株的野生型戊型肝炎病毒攻击后出现病毒性肝炎的生化证据。与未免疫(对照)的食蟹猴形成鲜明对比的是,在用野生型戊型肝炎病毒攻击后,两只免疫动物的丙氨酸转氨酶活性均未升高。在用缅甸戊型肝炎病毒攻击的食蟹猴中,保护作用是完全的,该动物未表现出任何戊型肝炎病毒感染的证据。用缅甸戊型肝炎病毒攻击的免疫食蟹猴粪便中未检测到任何戊型肝炎病毒RNA,肝脏中也未检测到戊型肝炎病毒抗原。用墨西哥病毒攻击的免疫食蟹猴(#8902)粪便中出现了戊型肝炎病毒RNA,肝脏中出现了戊型肝炎病毒抗原;然而,对该食蟹猴肝脏活检标本的显微镜检查未发现病毒性肝炎的组织病理学证据。所有动物(未免疫和免疫的)在受到戊型肝炎病毒攻击后均产生了抗戊型肝炎病毒IgM和IgG反应。我们的初步研究表明,trpE-C2蛋白是一种有前景的戊型肝炎病毒候选疫苗。

相似文献

1
Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV).初步证据表明,一种色氨酸合成酶E(trpE)-戊型肝炎病毒(HEV)融合蛋白可保护食蟹猴免受野生型戊型肝炎病毒(HEV)攻击。
J Med Virol. 1993 Sep;41(1):90-4. doi: 10.1002/jmv.1890410118.
2
[Preliminary evidence that a hepatitis E virus (HEV) ORF2 recombinant protein protects cynomolgus macaques against challenge with wild-type HEV].[戊型肝炎病毒(HEV)ORF2重组蛋白保护食蟹猴免受野生型HEV攻击的初步证据]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2002 Mar;16(1):31-2.
3
Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection.基因枪接种戊型肝炎病毒DNA疫苗在食蟹猴感染模型中的保护效力
J Infect Dis. 2004 Jan 15;189(2):258-64. doi: 10.1086/380801. Epub 2004 Jan 8.
4
Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4.戊型肝炎病毒4型重组ORF2蛋白在恒河猴中的免疫原性和保护效果
Arch Virol. 2009;154(3):481-8. doi: 10.1007/s00705-009-0335-7. Epub 2009 Feb 25.
5
DNA vaccination against hepatitis E virus infection in cynomolgus macaques.食蟹猴中针对戊型肝炎病毒感染的DNA疫苗接种
J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S365-9. doi: 10.1046/j.1440-1746.17.s3.29.x.
6
Cross-protection of hepatitis E virus genotypes 1 and 4 in rhesus macaques.恒河猴中戊型肝炎病毒1型和4型的交叉保护作用。
J Med Virol. 2008 May;80(5):824-32. doi: 10.1002/jmv.21140.
7
Neutralization of different geographic strains of the hepatitis E virus with anti-hepatitis E virus-positive serum samples obtained from different sources.用从不同来源获得的抗戊型肝炎病毒阳性血清样本对不同地理株的戊型肝炎病毒进行中和。
Virology. 1998 Sep 30;249(2):316-24. doi: 10.1006/viro.1998.9346.
8
Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs.评估来自猪、鼠和禽源戊型肝炎病毒(HEV)的重组衣壳蛋白对猪感染基因型 3 HEV 的交叉保护能力。
Vaccine. 2012 Sep 28;30(44):6249-55. doi: 10.1016/j.vaccine.2012.08.013. Epub 2012 Aug 17.
9
Immunogenicity and efficacy of a bacterially expressed HEV ORF3 peptide, assessed by experimental infection of primates.经灵长类动物实验感染评估,一种由细菌表达的戊型肝炎病毒 ORF3 肽的免疫原性和功效。
Arch Virol. 2009;154(10):1641-8. doi: 10.1007/s00705-009-0496-4. Epub 2009 Sep 15.
10
Expression of a hepatitis E virus (HEV)-trpE fusion protein containing epitopes recognized by antibodies in sera from human cases and experimentally infected primates.
Arch Virol. 1992;123(3-4):335-49. doi: 10.1007/BF01317268.

引用本文的文献

1
Hepatitis E virus: from innate sensing to adaptive immune responses.戊型肝炎病毒:从先天感应到适应性免疫反应。
Nat Rev Gastroenterol Hepatol. 2024 Oct;21(10):710-725. doi: 10.1038/s41575-024-00950-z. Epub 2024 Jul 22.
2
The Re-Emergence of Hepatitis E Virus in Europe and Vaccine Development.戊型肝炎病毒在欧洲的再现与疫苗研发。
Viruses. 2023 Jul 16;15(7):1558. doi: 10.3390/v15071558.
3
Prophylactic Hepatitis E Vaccine.预防性戊型肝炎疫苗。
Adv Exp Med Biol. 2023;1417:227-245. doi: 10.1007/978-981-99-1304-6_16.
4
Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review.近年来肝炎病毒保护性疫苗的研究进展:叙述性综述。
Viruses. 2023 Jan 12;15(1):214. doi: 10.3390/v15010214.
5
[Vaccines against hepatitis E virus: state of development].[戊型肝炎病毒疫苗:研发进展]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Feb;65(2):192-201. doi: 10.1007/s00103-022-03487-1. Epub 2022 Jan 31.
6
The Hepatitis E Virus Open Reading Frame 2 Protein: Beyond Viral Capsid.戊型肝炎病毒开放阅读框2蛋白:超越病毒衣壳
Front Microbiol. 2021 Oct 7;12:739124. doi: 10.3389/fmicb.2021.739124. eCollection 2021.
7
Immunogenicity of gold nanoparticle-based truncated ORF2 vaccine in mice against Hepatitis E virus.基于金纳米颗粒的截短型ORF2疫苗对小鼠抗戊型肝炎病毒的免疫原性。
3 Biotech. 2021 Feb;11(2):49. doi: 10.1007/s13205-020-02573-y. Epub 2021 Jan 11.
8
Synthetic Peptides Containing Three Neutralizing Epitopes of Genotype 4 Swine Hepatitis E Virus ORF2 induced Protection against Swine HEV Infection in Rabbit.包含4型猪戊型肝炎病毒ORF2三个中和表位的合成肽诱导兔抵抗猪戊型肝炎病毒感染的保护作用。
Vaccines (Basel). 2020 Apr 13;8(2):178. doi: 10.3390/vaccines8020178.
9
Development of new hepatitis E vaccines.新型戊型肝炎疫苗的研制。
Hum Vaccin Immunother. 2018;14(9):2254-2262. doi: 10.1080/21645515.2018.1469591. Epub 2018 Jun 18.
10
Nonhuman Primate Models of Hepatitis A Virus and Hepatitis E Virus Infections.甲型肝炎病毒和戊型肝炎病毒感染的非人灵长类动物模型。
Cold Spring Harb Perspect Med. 2019 Feb 1;9(2):a031815. doi: 10.1101/cshperspect.a031815.